Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG-Guided Lymph Node Dissection in Esophageal Cancer
NCT04615806Unknown
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Sep 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of indocyanine green in esophageal cancer (2 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoints: Accuracy rate of lymph node dissection at 1 week, False positive rate of lymph node dissection at 1 week and 3 more. Status: unknown.
02
Drugs
indocyanine green
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT04615806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04615806.